How We Will Shift Global Health Policy & Funding
Evolve Global Health Funding
We’ll work with current donors to crowd-in capital through private financiers, innovative philanthropic models, and new funding mechanisms like impact investing and venture funds.
We’ll partner with medical technology companies and venture funds that invest in tech entrepreneurs with great ideas in search of scale.
We’ll mobilize resources within the countries where we work in three ways:
By securing national/provincial government grants to assist national/provincial governments in designing and delivering solutions to move quality care closer to consumers and reduce overall healthcare spending.
By working with national and third party insurers to arrange for reimbursement in PSI managed service delivery.
By developing social enterprises where consumers can pay without financial hardship.
Influence Global and National Priorities
We’ll translate consumer and market insights into clear information that helps national and local governments, international donors and policy makers make better policy and funding decisions, leading to healthier global, regional and national markets and better outcomes for consumers.
We’ll advocate for greater consumer choice in healthcare through public or private channels under UHC.
We’ll join discussions that help shape national five-year strategic plans and Universal Health Coverage and primary care agendas.
Build a Movement
We’ll drive learning and thought-leadership about consumer powered healthcare among opinion and thought leaders, communities of practice, and the wider public, sharing lessons and successes, demonstrating effectiveness, and helping to shape a narrative that is friendly to what we want to achieve over the coming decade.
We’ll foster shared value (public/private) partnerships driven by the vision of consumer-empowered healthcare.
Providing even more individuals the ability to design their own healthcare.
Discover what's happening at PSI
Ask Kelly: ETHICS DURING COVID-19- Returning to In-person Research
By: Kelly O’Keefe, Research Ethics Senior Technical Advisor, PSI; Jennifer Wheeler, Deputy Director for Research, PSI; and Kristen Little, Senior Technical Advisor, Strategic Research, PSI Since the
In Memoriam to Bill Gates, Sr.
By Karl Hofmann, President & CEO, PSI Let me add our voices to those who have paid tribute to Bill Gates, Sr. His remarkable contributions to the work of
Infected and Affected: The Indirect Consequences of COVID-19 in Central America
By Jennifer Wheeler, PSI Deputy Director, Research, Paola Letona, PSI Evidence Regional Director, LAC, and Sussy Lungo, Regional Executive Director, Asociación PASMO “When you are
Five Market Indicators that Signal the Hormonal IUS will take off
By Kendal Danna, PSI Technical Advisor, Reproductive Health In 2017, with USAID support, PSI began piloting the introduction of the hormonal Intrauterine System (IUS), also